Abstract: A gas detector (10) that is arranged to sense the concentration levels of target gases oxygen, methane, carbon monoxide, and hydrogen sulphide, within a gas sample from an environment surrounding the detector. The gas detector (10) comprises laser sources (12a-12d) that are arranged to transmit radiation through the gas sample at four target wavelengths that correspond approximately to the optimum absorption wavelengths of each of the target gases and an optical detector (16) that is arranged to sense the intensity of the radiation transmitted through the gas sample at each of the target wavelengths. A control system (22) generates representative concentration level information for the target gases based on the level of absorption of the radiation transmitted.

Abstract: A method and apparatus for processing documents is provided. Documents having a selected characteristic are placed into a first area, whereas documents not having the selected characteristic are placed into a second area. A sensor in the first area detects the presence of documents in the first area. The documents are conveyed to a scanner that scans the documents to obtain information regarding the documents. The processing of the documents is controlled by a processor. A document is electronically tagged as having the selected characteristic and processed accordingly in response to the detection of the document in the first area and in response to whether the document arrived at the scanner during a pre-determined time frame.

Abstract: The present invention relates generally to a nebulizer, and more particularly but not exclusively to a compact nebulizer that may include an angled impactor and/or siphon tube integrated into the impactor to increase the nebulizer efficiency.

Abstract: This invention provides cellular gene products which have anti-apoptotic activity in HIV-1 infected cells and provides agents for the inhibition of the cellular gene products.

Abstract: Disclosed is a novel solid dosage unit, preferably in the form of a film or thin troche, containing at least one pharmaceutical agent, and its method of manufacture, which involves introduction of a fluid containing at least one non-volatile material, such as a polymeric film forming substance, a volatile carrier and at least one pharmaceutical agent into a depression or cavity comprising the major element of the packaging film for the finished dosage unit (s), and removing the volatile carrier from the cavity by exposure to radiant energy, whereby the remaining non-volatile residue comprises the desired dosage unit. The packaging film can be subsequently lidded by conventional sealing methods to produce packaged dosage units which are suitable for sublingual and other oral applications.

Abstract: A method and system are provided to report the findings of an expert's analysis of image data. The method and system are based on a reporting system that forms the basis of an image management system that can efficiently and systematically generate image reports, facilitate data entry into searchable databases for data mining, and expedite billing and collections for the expert's services. The expert identifies a significant finding on an image and attaches a location:description code to the location of that finding in order to create a significant finding and an entry into a database. Further descriptions of that finding, such as dimensional measurements, may be automatically appended to the finding as secondary attributes. After the evaluation, the system sorts the findings in the database and presents the findings by prioritized categories. The expert edits and approves a multimedia report which may be delivered by electronic means to an end-user.

Abstract: An optically readable sheet has plural mark spaces and has at least two fiducial marks defining the orientation and scaling of the sheet. A method for reading an optically readable sheet may comprise imaging the sheet and decoding the fiducial marks from the image of the sheet for scaling the image of the sheet and decoding the mark spaces therein. Scaling the image may include comparing the locations of the decoded fiducial marks from the image of the sheet and the predetermined locations of the fiducial marks on the sheet.

Abstract: Antimicrobial peptides and methods of identifying the same are provided.

Abstract: A drag racing roller coaster amusement ride has at least two sets running rails, each set having at least one running rail and an embark point. At least two carriers (109) are arranged to carry at least one rider on a respective set of running rails with the rider(s) in a substantially prone position. Each carrier is arranged to slidingly engage with the respective set of running rails to enable the carriers to traverse the ride. The ride has an indicator (109) to provide a ride commencement indication. A launch system is configured to provide a powered initial motion to each carrier. Each carrier has a ride activator controllable by a rider of the carrier to trigger the launch system to commence the ride for the carrier following the ride commencement indication. Launch systems are also disclosed.

Abstract: A method for reading a sheet or a paper ballot enclosed in a ballot envelope comprises decoding a machine readable envelope identifier from each ballot envelope, displaying at least the decoded envelope identifier and a signature from each ballot envelope for determining from the envelope identifier, the signature, or both, whether a valid sheet or ballot is presented. If the sheet or ballot is valid, then the sheet or ballot is removed from its envelope and the selections marked on the sheet or ballot may then be determined and processed.

Abstract: A conveyor having conveyor chain 100 adapted to be engaged and driven by drums 180 and 190 having spiral flights. The conveyor chain has a number of interconnected conveying modules 120, 140, 150 and 160. Selected modules 120 are aligned in the direction of travel parallel to the axis of rotation of the drums. Each of the aligned modules has a traveling guide socket 122 on the back surface, which engages with flight portions 180a and 190a of the spiral drums, so that the chain is advanced by the rotation of the drums. The modules are rectangular and are interconnected in columns and rows, preferably in a brick pattern.

Abstract: A bearing roller chain which is sealed by a seal mechanism which prevents entry of foreign substances from the outside and leakage of lubricating oil leakage from the inside to the outside, resulting in an improvement in wear resistance of the bearing roller and avoidance both of rotation failure of the roller and of increased traveling resistance of the chain. A seal mechanism is provided between an inner link plate of a bearing roller chain and a bearing roller assembly carried by the link plate. The bearing roller assembly is formed by a plurality of anti-friction rollers between a hollow roller and a bush. The seal mechanism comprises an inner annular oil seal member, a spacer and a disk-shaped seal member having a flange extended toward an outer side surface of the hollow roller loosely into an outer circumferential concave groove on an end surface of the hollow roller. The disk-shaped seal member slidably comes into close contact with the inner link plate and the spacer, respectively.

Abstract: Provided are degradation-resistant fibrinogen sealants comprising a first composition comprising one or more of fibrinogen ?A/?? heterodimers and/or fibrinogen ??/?? homodimers and a second composition comprising thrombin and, optionally, degradation-resistant fibrinogen sealants disclosed herein may further comprise Factor XIII and calcium. Degradation-resistant fibrinogen sealants are suitable for the treatment of trauma, particularly vascular trauma.

Abstract: The present invention relates to rotary motors in which the rotational motion of the motor is provided by the attractive (or repulsive) forces between a pair of cooperating magnets in response to tilting of the motor axle.

Abstract: Specific binding members against extracellular matrix protein tenascin-C, especially scFv antibody molecules against domain A1, domain C and domain D of tenascin-C. Anti-tenascin-C specific binding members conjugated with labels, cytotoxic molecules or cytokines. Use of anti-tenascin-C specific binding members in diagnosis and treatment, especially of cancer.

Abstract: There is disclosed a vehicle seat provided with a system for facilitating relieving of fatigue of a person driving a vehicle, the vehicle seat comprising a seat back (1) having a pad (5), the system including an occupant's body-motion promoting mechanism (12) provided in the seat back so as to be arranged behind the pad for locally pressing an occupant's body during driving of the vehicle and releasing the occupant's body from pressure, thereby moving the occupant's body and promoting blood circulation of the person. The occupant's body-motion promoting mechanism is configured to intermittently perform repeated pressing/releasing operations with respect to the third lumbar vertebrae of the occupant in a range of three to seven times, at a stroke amount in a range of 10 mm to 20 mm, and at a time interval of 5 minutes to 10 minutes.

Abstract: A powered unicycle (100) having a wheel (105) driven by a motor (107) and a control system arranged to automatically maintain the fore-aft balance of the unicycle (100) via operation of the motor (107). The unicycle (100) also includes a handle bar (102), coupled to the wheel (105) by a pillar (101), which is operable to steer the wheel (105), and a rider-support (109) which is pivotable relative to the wheel.

Abstract: Covalently reactive antigen analogs are disclosed herein. The antigens of the invention may be used to stimulate production of catalytic antibodies specific for predetermined antigens associated with particular medical disorders. The antigen analogs may also be used to permanently inactivate endogenously produced catalytic antibodies produced in certain autoimmune diseases as well as in certain lymphoproliferative disorders. Also provided are methods for modulating the efficacy of nucleic acid based therapeutics.